Evidence map›Paper›PMID 32782565›Full record

ArticleOncology letters2020

Biomarker phenotyping drives clinical management in axillary sentinel node: A retrospective study on women with primary breast cancer in 2002.

Sergio Diotaiuti, Simona De Summa, Rosanna Altieri, Caterina Dantona, Stefania Tommasi, Maria Di Gennaro, Giuseppe Rubini, Maria Irene Pastena, Antonella Argentiero, Francesco Alfredo Zito and 2 more

Abstract read
In one paragraph

Article in Oncology letters, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sergio DiotaiutiSenology Unit, IRCCS Istituto Tumori 'Giovanni Paolo II' of Bari, I-70124 Bari, Italy.
Simona De SummaMolecular Biology and Pharmacogenomics Laboratory, IRCCS Istituto Tumori 'Giovanni Paolo II' of Bari, I-70124 Bari, Italy.
Rosanna AltieriSenology Unit, IRCCS Istituto Tumori 'Giovanni Paolo II' of Bari, I-70124 Bari, Italy.
Caterina DantonaSenology Unit, IRCCS Istituto Tumori 'Giovanni Paolo II' of Bari, I-70124 Bari, Italy.
Stefania TommasiMolecular Biology and Pharmacogenomics Laboratory, IRCCS Istituto Tumori 'Giovanni Paolo II' of Bari, I-70124 Bari, Italy.
Maria Di GennaroExperimental Oncology Unit, IRCCS Istituto Tumori 'Giovanni Paolo II' of Bari, I-70124 Bari, Italy.
Giuseppe RubiniNuclear Medicine Institute, University of Bari 'Aldo Moro', I-70124 Bari, Italy.
Maria Irene PastenaHistopathology Unit, IRCCS Istituto Tumori 'Giovanni Paolo II' of Bari, I-70124 Bari, Italy.
Antonella ArgentieroMedical Oncology Unit, IRCCS Istituto Tumori 'Giovanni Paolo II' of Bari, I-70124 Bari, Italy.
Francesco Alfredo ZitoHistopathology Unit, IRCCS Istituto Tumori 'Giovanni Paolo II' of Bari, I-70124 Bari, Italy.
Nicola SilvestrisMedical Oncology Unit, IRCCS Istituto Tumori 'Giovanni Paolo II' of Bari, I-70124 Bari, Italy.
Angelo Virgilio ParadisoExperimental Oncology Unit, IRCCS Istituto Tumori 'Giovanni Paolo II' of Bari, I-70124 Bari, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current study examined if cancer biomarker phenotyping could predict the clinical/pathological status of axillary nodes in women with primary breast cancer. Primary breast cancers from 2002 were analyzed for tumor size, estrogen receptor (ER), progesterone receptor (PgR), Ki-67MIB expression and Her2/neu amplification. Relationships between the clinical and pathological status of the axilla and the biological subtypes classification were analyzed using univariate, multivariate and regression tree analysis. A total of 65% of women with axillary nodes clinically involved had complete axillary node dissection (ALND) while 705 women with clinically negative axillary underwent sentinel lymph node biopsy (SLNB), 18.5% of the latter had at least one pathologically SLNB involved node. Multivariate analysis revealed that the Luminal A subtype was significantly associated (OR 0.62; P<10

Indexed as

axillary nodebreast cancersentinel nodesubtyping

Identifiers

PMID32782565
PMCPMC7399785

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.